Recent Guidelines

Displaying 1 - 8 out of 8 guidelines found

  1. Practice Guideline Recommendations Summary: Disease-modifying Therapies for Adults with Multiple Sclerosis

    April 2018

    Recommendations from current practice guideline. Endorsed by the Multiple Sclerosis Association of America and the National Multiple Sclerosis Society. Companion to "Systematic Review Summary: Disease-modifying Therapies for Adults with Multiple Sclerosis" (April 2018).

  2. Comprehensive Systematic Review Summary: Disease-modifying Therapies for Adults with Multiple Sclerosis

    April 2018

    Systematic review summary from current practice guideline. Endorsed by the Multiple Sclerosis Association of America and the National Multiple Sclerosis Society. Companion to "Practice Guideline Recommendations Summary: Disease-modifying Therapies for Adults with Multiple Sclerosis" (April 2018).

  3. Comprehensive Systematic Review Summary: Treatment of Cerebellar Motor Dysfunction and Ataxia

    February 2018

    Current systematic review. Endorsed by the A-TCP Children's Project.

  4. Practice Guideline Update Summary: Mild Cognitive Impairment

    December 2017

    Current guideline. Endorsed by the Alzheimer's Association.

  5. Practice Guideline: Cervical and Ocular Vestibular Evoked Myogenic Potential Testing

    November 2017

    Current practice guideline.

  6. Practice Guideline: Reducing Brain Injury After Cardiopulmonary Resuscitation

    May 2017

    Current guideline. Endorsed by the Neurocritical Care Society.

  7. Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors

    April 2017

    Current guideline. Codeveloped with the American Epilepsy Society and endorsed by the International Child Neurology Association.

  8. Practice Guideline Summary: Use of fMRI in the Presurgical Evaluation of Patients with Epilepsy

    January 2017

    Current guideline. Endorsed by the American College of Radiology and the American Epilepsy Society.

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer